Two areas that suffered relatively light damage, however, were pharmaceuticals and biotech. The main reason ... they were concentrating on levies being phased in, as opposed to the full 25% ...

Shares of the biotech Kymera Therapeutics are up 50% since Monday, when data from an early trial hinted that its pill might ...

Pharmaceutical and biotech stocks often are ... In injectable format, VK2735 is set to enter phase 3 development; the oral formulation is getting ready to enter phase 2. Viking's stock price ...

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...

Initiated in December 2024, the Phase 2b ZUPREME-1 trial ... 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of ...

Cairo, Egypt: The Medicine City "GYPTO Pharma", one of the largest pharmaceutical manufacturing hubs in the Middle East, announced today the completion of the first phase of transferring ... this ...